OPIANT PHARMACEUTICALS, INC.

2022 Q4 Form 10-Q Financial Statement

#000138550822000131 Filed on November 14, 2022

View on sec.gov

Income Statement

Concept 2022 Q4 2022 Q3

Balance Sheet

Concept 2022 Q4 2022 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $35.38M
YoY Change -29.67%
Cash & Equivalents $35.40M
Short-Term Investments $0.00
Other Short-Term Assets $3.131M
YoY Change 47.62%
Inventory
Prepaid Expenses
Receivables $41.11K
Other Receivables $0.00
Total Short-Term Assets $38.55M
YoY Change -43.21%
LONG-TERM ASSETS
Property, Plant & Equipment $417.6K
YoY Change 346.59%
Goodwill
YoY Change
Intangibles $10.60K
YoY Change -11.47%
Long-Term Investments
YoY Change
Other Assets $234.0K
YoY Change
Total Long-Term Assets $3.402M
YoY Change 208.35%
TOTAL ASSETS
Total Short-Term Assets $38.55M
Total Long-Term Assets $3.402M
Total Assets $41.95M
YoY Change -39.18%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $3.113M
YoY Change 20.62%
Accrued Expenses $2.491M
YoY Change 52.36%
Deferred Revenue $0.00
YoY Change
Short-Term Debt $0.00
YoY Change
Long-Term Debt Due $1.437M
YoY Change
Total Short-Term Liabilities $7.040M
YoY Change -4.24%
LONG-TERM LIABILITIES
Long-Term Debt $12.32M
YoY Change -34.81%
Other Long-Term Liabilities $2.084M
YoY Change 190.86%
Total Long-Term Liabilities $14.41M
YoY Change -26.57%
TOTAL LIABILITIES
Total Short-Term Liabilities $7.040M
Total Long-Term Liabilities $14.41M
Total Liabilities $21.45M
YoY Change -20.49%
SHAREHOLDERS EQUITY
Retained Earnings -$95.52M
YoY Change 53.0%
Common Stock $116.3M
YoY Change 11.3%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $20.50M
YoY Change
Total Liabilities & Shareholders Equity $41.95M
YoY Change -39.18%

Cashflow Statement

Concept 2022 Q4 2022 Q3

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Amendment Flag
AmendmentFlag
false
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Entity Central Index Key
EntityCentralIndexKey
0001385508
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2022-09-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-38193
dei Entity Registrant Name
EntityRegistrantName
OPIANT PHARMACEUTICALS, INC.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
46-4744124
dei Entity Address Address Line1
EntityAddressAddressLine1
233 Wilshire Blvd.
dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 400
dei Entity Address City Or Town
EntityAddressCityOrTown
Santa Monica,
dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
90401
dei City Area Code
CityAreaCode
310
dei Local Phone Number
LocalPhoneNumber
598-5410
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2021Q4 us-gaap Assets Current
AssetsCurrent
69158964 usd
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2022Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
5167814 shares
dei Security12b Title
Security12bTitle
Common stock, par value $0.001 per share
dei Trading Symbol
TradingSymbol
OPNT
dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2022Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
35375865 usd
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
37853947 usd
CY2022Q3 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
0 usd
CY2021Q4 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
15014750 usd
CY2022Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
41113 usd
CY2021Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
13327364 usd
CY2022Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
3131299 usd
CY2021Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
2962903 usd
CY2022Q3 us-gaap Assets Current
AssetsCurrent
38548277 usd
CY2022Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
417646 usd
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
78107 usd
CY2022Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
2739239 usd
CY2021Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
999567 usd
CY2022Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
10598 usd
CY2021Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
11628 usd
CY2022Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
234389 usd
CY2021Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
179532 usd
CY2022Q3 us-gaap Assets
Assets
41950149 usd
CY2021Q4 us-gaap Assets
Assets
70427798 usd
CY2022Q3 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
3113068 usd
CY2021Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
3369848 usd
CY2022Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
1821438 usd
CY2021Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
201254 usd
CY2022Q3 us-gaap Accrued Royalties Current
AccruedRoyaltiesCurrent
0 usd
CY2021Q4 us-gaap Accrued Royalties Current
AccruedRoyaltiesCurrent
2920148 usd
CY2021Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
16618 usd
CY2022Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
669209 usd
CY2022Q3 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
0 usd
CY2021Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
337690 usd
CY2022Q3 us-gaap Convertible Debt Current
ConvertibleDebtCurrent
1436660 usd
CY2021Q4 us-gaap Convertible Debt Current
ConvertibleDebtCurrent
0 usd
CY2022Q3 us-gaap Liabilities Current
LiabilitiesCurrent
7040375 usd
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
6845558 usd
CY2022Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
2083548 usd
CY2021Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
673347 usd
CY2022Q3 us-gaap Long Term Debt
LongTermDebt
12324237 usd
CY2021Q4 us-gaap Long Term Debt
LongTermDebt
16069085 usd
CY2022Q3 us-gaap Liabilities
Liabilities
21448160 usd
CY2021Q4 us-gaap Liabilities
Liabilities
23587990 usd
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000 shares
CY2022Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000 shares
CY2022Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
5164951 shares
CY2022Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
5164951 shares
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
4909846 shares
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
4909846 shares
CY2022Q3 us-gaap Common Stock Value
CommonStockValue
5165 usd
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
4910 usd
CY2022Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
116266243 usd
CY2021Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
108569988 usd
CY2022Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-248129 usd
CY2021Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-54815 usd
CY2022Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-95521290 usd
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-61680275 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
20501989 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
46839808 usd
CY2022Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
41950149 usd
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
70427798 usd
CY2022Q3 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
0 usd
CY2021Q3 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
14041006 usd
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
4519505 usd
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
27688713 usd
CY2022Q3 opnt Revenuefrom Grantsand Contracts
RevenuefromGrantsandContracts
173874 usd
CY2021Q3 opnt Revenuefrom Grantsand Contracts
RevenuefromGrantsandContracts
2298055 usd
opnt Revenuefrom Grantsand Contracts
RevenuefromGrantsandContracts
4018653 usd
opnt Revenuefrom Grantsand Contracts
RevenuefromGrantsandContracts
6296542 usd
CY2022Q3 us-gaap Revenues
Revenues
173874 usd
CY2021Q3 us-gaap Revenues
Revenues
16339061 usd
us-gaap Revenues
Revenues
8538158 usd
us-gaap Revenues
Revenues
33985255 usd
CY2022Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3073114 usd
CY2021Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3378707 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
11415746 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
8758601 usd
CY2022Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
4133982 usd
CY2021Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
4881398 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
20873449 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
12119088 usd
CY2022Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
2596562 usd
CY2021Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
1059649 usd
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
8088860 usd
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
3080211 usd
CY2022Q3 us-gaap Royalty Expense
RoyaltyExpense
0 usd
CY2021Q3 us-gaap Royalty Expense
RoyaltyExpense
3058865 usd
us-gaap Royalty Expense
RoyaltyExpense
943269 usd
us-gaap Royalty Expense
RoyaltyExpense
6145057 usd
CY2022Q3 us-gaap Operating Expenses
OperatingExpenses
9803658 usd
CY2021Q3 us-gaap Operating Expenses
OperatingExpenses
12378619 usd
us-gaap Operating Expenses
OperatingExpenses
41321324 usd
us-gaap Operating Expenses
OperatingExpenses
30102957 usd
CY2022Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-9629784 usd
CY2021Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
3960442 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-32783166 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
3882298 usd
CY2022Q3 us-gaap Interest And Dividend Income Operating
InterestAndDividendIncomeOperating
160114 usd
CY2021Q3 us-gaap Interest And Dividend Income Operating
InterestAndDividendIncomeOperating
3498 usd
us-gaap Interest And Dividend Income Operating
InterestAndDividendIncomeOperating
227830 usd
us-gaap Interest And Dividend Income Operating
InterestAndDividendIncomeOperating
10334 usd
CY2022Q3 us-gaap Interest Expense
InterestExpense
390850 usd
CY2021Q3 us-gaap Interest Expense
InterestExpense
547296 usd
us-gaap Interest Expense
InterestExpense
1213021 usd
us-gaap Interest Expense
InterestExpense
1626273 usd
CY2022Q3 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
-49437 usd
CY2021Q3 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
0 usd
us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
-49437 usd
us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
0 usd
CY2022Q3 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
1868 usd
CY2021Q3 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
455 usd
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
17818 usd
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-9899 usd
CY2022Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-278305 usd
CY2021Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-543343 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-1016810 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-1625838 usd
CY2022Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-9908089 usd
CY2021Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
3417099 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-33799976 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
2256460 usd
CY2022Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
8550 usd
CY2021Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
41039 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-9916639 usd
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
3417099 usd
us-gaap Net Income Loss
NetIncomeLoss
-33841015 usd
us-gaap Net Income Loss
NetIncomeLoss
2256460 usd
CY2022Q3 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-4979 usd
CY2021Q3 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-7974 usd
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-193314 usd
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
81 usd
CY2022Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-9921618 usd
CY2021Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
3409125 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-34034329 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
2256541 usd
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.93
CY2021Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.77
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-6.66
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.52
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.93
CY2021Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.56
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-6.66
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.41
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
5138274 shares
CY2021Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
4462236 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
5083222 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
4359759 shares
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
5138274 shares
CY2021Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
6065044 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
5083222 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
5565065 shares
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
46839808 usd
CY2022Q1 us-gaap Adjustments To Additional Paid In Capital Other
AdjustmentsToAdditionalPaidInCapitalOther
5824 usd
CY2022Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
91634 usd
CY2022Q1 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
0 usd
CY2022Q1 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
2571200 usd
CY2022Q1 opnt Adjustments To Additional Paid In Capital Debt Issuance Costs
AdjustmentsToAdditionalPaidInCapitalDebtIssuanceCosts
109399 usd
CY2022Q1 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
2079159 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-12187830 usd
CY2022Q1 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-27150 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
39263246 usd
CY2022Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
0 usd
CY2022Q2 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
0 usd
CY2022Q2 opnt Stock Issued During Period Value Performance Stock Award
StockIssuedDuringPeriodValuePerformanceStockAward
0 usd
CY2022Q2 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
135678 usd
CY2022Q2 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
2095118 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-11736546 usd
CY2022Q2 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-161185 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
29596311 usd
CY2022Q3 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
0 usd
CY2022Q3 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
402615 usd
CY2022Q3 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
424681 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-9916639 usd
CY2022Q3 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-4979 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
20501989 usd
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
35492242 usd
CY2021Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
579619 usd
CY2021Q1 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
0 usd
CY2021Q1 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
745620 usd
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-2844230 usd
CY2021Q1 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
12501 usd
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
33985752 usd
CY2021Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
36605 usd
CY2021Q2 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
0 usd
CY2021Q2 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
654562 usd
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
1683591 usd
CY2021Q2 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-4446 usd
CY2021Q3 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
694334 usd
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
36356064 usd
CY2021Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
1545834 usd
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
3417099 usd
CY2021Q3 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-7974 usd
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
42005357 usd
us-gaap Net Income Loss
NetIncomeLoss
-33841015 usd
us-gaap Net Income Loss
NetIncomeLoss
2256460 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
28013 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
78701 usd
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
153613 usd
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
205177 usd
us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
-49437 usd
us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
0 usd
opnt Operating Lease Expense Non Cash
OperatingLeaseExpenseNonCash
384916 usd
opnt Operating Lease Expense Non Cash
OperatingLeaseExpenseNonCash
388598 usd
us-gaap Stock Option Plan Expense
StockOptionPlanExpense
4598958 usd
us-gaap Stock Option Plan Expense
StockOptionPlanExpense
2094516 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-13286251 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
6514964 usd
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
296020 usd
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-860631 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-198361 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-481464 usd
us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
1672129 usd
us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
553996 usd
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-370033 usd
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-392564 usd
us-gaap Increase Decrease In Royalties Payable
IncreaseDecreaseInRoyaltiesPayable
-2920148 usd
us-gaap Increase Decrease In Royalties Payable
IncreaseDecreaseInRoyaltiesPayable
1228605 usd
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-16618 usd
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-354756 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-17468878 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-77064 usd
us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
15014750 usd
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
15044750 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
418962 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
0 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
14595788 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-15044750 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
538293 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
0 usd
opnt Proceeds From Stock Options And Warrants Exercised
ProceedsFromStockOptionsAndWarrantsExercised
97458 usd
opnt Proceeds From Stock Options And Warrants Exercised
ProceedsFromStockOptionsAndWarrantsExercised
2162058 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
635751 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
2162058 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-240743 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-6985 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-2478082 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-12966741 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
37853947 usd
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
48251336 usd
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
35375865 usd
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
35284595 usd
us-gaap Interest Paid Net
InterestPaidNet
1158940 usd
us-gaap Interest Paid Net
InterestPaidNet
1051508 usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
66924 usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 usd
us-gaap Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
2571200 usd
us-gaap Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
0 usd
opnt Adjustments To Additional Paid In Capital Debt Issuance Costs
AdjustmentsToAdditionalPaidInCapitalDebtIssuanceCosts
109399 usd
opnt Adjustments To Additional Paid In Capital Debt Issuance Costs
AdjustmentsToAdditionalPaidInCapitalDebtIssuanceCosts
0 usd
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
2106776 usd
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
1094259 usd
us-gaap Stock Issued1
StockIssued1
73 usd
us-gaap Stock Issued1
StockIssued1
19 usd
us-gaap Use Of Estimates
UseOfEstimates
The preparation of condensed consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities, and reported amounts of expenses in the financial statements and accompanying notes. Actual results could differ from those estimates. Key estimates included in the financial statements include the valuation of: deferred income tax assets, equity instruments, stock-based compensation, acquired intangibles, and allowances for accounts receivable.
CY2022Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
35400000 usd
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
37900000 usd
CY2022Q3 us-gaap Cash Fdic Insured Amount
CashFDICInsuredAmount
250000 usd
CY2022Q3 opnt Cash Fscs Insured Amount
CashFSCSInsuredAmount
85000 gbp
CY2022Q3 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.088
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-9917000 usd
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
3417000 usd
us-gaap Net Income Loss
NetIncomeLoss
-33841000 usd
us-gaap Net Income Loss
NetIncomeLoss
2256000 usd
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
5138274 shares
CY2021Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
4462236 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
5083222 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
4359759 shares
CY2022Q3 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
0 shares
CY2021Q3 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
1602808 shares
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
0 shares
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
1205306 shares
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
5138274 shares
CY2021Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
6065044 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
5083222 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
5565065 shares
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.93
CY2021Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.77
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-6.66
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.52
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.93
CY2021Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.56
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-6.66
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.41
CY2022Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
3535225 shares
CY2021Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
804715 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
3535225 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
938565 shares
CY2022Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
3100000 usd
CY2021Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
3000000 usd
opnt Lessee Operating Lease Number Of Leases
LesseeOperatingLeaseNumberOfLeases
2 lease
CY2022Q3 us-gaap Lessee Operating Lease Renewal Term
LesseeOperatingLeaseRenewalTerm
P5Y
CY2022Q3 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P4Y7M6D
CY2022Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
2739000 usd
CY2022Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
669000 usd
CY2022Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
2084000 usd
CY2022Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
2753000 usd
CY2022Q3 us-gaap Operating Lease Cost
OperatingLeaseCost
149000 usd
us-gaap Operating Lease Cost
OperatingLeaseCost
395000 usd
CY2022Q3 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
179000 usd
CY2022Q3 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
709000 usd
CY2022Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
737000 usd
CY2022Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
780000 usd
CY2022Q3 opnt Lessee Operating Lease Liability To Be Paid After Year Three
LesseeOperatingLeaseLiabilityToBePaidAfterYearThree
1036000 usd
CY2022Q3 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
3441000 usd
CY2022Q3 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
688000 usd
CY2022Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
2753000 usd
CY2022Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
234000 usd
CY2021Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
180000 usd
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
4500000 usd
CY2018Q2 us-gaap Grants Receivable
GrantsReceivable
7400000 usd
CY2021Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
17000 usd
opnt Contractwith Customer Liability Additions
ContractwithCustomerLiabilityAdditions
0 usd
us-gaap Contract With Customer Liability Change In Timeframe Performance Obligation Satisfied Revenue Recognized
ContractWithCustomerLiabilityChangeInTimeframePerformanceObligationSatisfiedRevenueRecognized
17000 usd
CY2022Q3 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
0 usd
CY2022Q3 us-gaap Accrued Royalties Current
AccruedRoyaltiesCurrent
0 usd
CY2021Q4 us-gaap Accrued Royalties Current
AccruedRoyaltiesCurrent
2900000 usd
CY2022Q3 us-gaap Debt Longterm And Shortterm Combined Amount
DebtLongtermAndShorttermCombinedAmount
13800000 usd
CY2021Q4 us-gaap Long Term Debt
LongTermDebt
16100000 usd
us-gaap Debt Conversion Original Debt Amount1
DebtConversionOriginalDebtAmount1
2600000 usd
CY2022Q3 us-gaap Debt Instrument Convertible Conversion Price1
DebtInstrumentConvertibleConversionPrice1
19.64
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
92000 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
2300000 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
563000 usd
CY2022Q3 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
2700000 usd

Files In Submission

Name View Source Status
opnt-20220930_cal.xml Edgar Link unprocessable
opnt-20220930_def.xml Edgar Link unprocessable
opnt-20220930_htm.xml Edgar Link completed
opnt-20220930_pre.xml Edgar Link unprocessable
0001385508-22-000131-index-headers.html Edgar Link pending
0001385508-22-000131-index.html Edgar Link pending
0001385508-22-000131.txt Edgar Link pending
0001385508-22-000131-xbrl.zip Edgar Link pending
exhibit31109302022.htm Edgar Link pending
exhibit31209302022.htm Edgar Link pending
exhibit32109302022.htm Edgar Link pending
exhibit32209302022.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
opnt-20220930.htm Edgar Link pending
opnt-20220930.xsd Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
opnt-20220930_lab.xml Edgar Link unprocessable
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending